Assignee
CANCER REC TECH LTD
GB·59 granted patents·28 pending applications·1,129 citations·filing 1995–2015
Top patents by PatentIndex Score
87 records- 0197US6916949B2Methods of chemical systhesis of phenolic nitrogen mustard prodrugsCANCER REC TECH LTD·Filed 2002·Granted Jul 12, 2005·62 cites·54 claims
- 0296US6667337B2Combination therapy for cancerCANCER REC TECH LTD·Filed 2001·Granted Dec 23, 2003·136 cites·5 claims
- 0394US7951819B2Imidazo[4, 5-B]pyridin-2-one and oxazolo[4, 5-B] pyridin-2-one compounds and analogs thereof as cancer therapeutic compoundsCANCER REC TECH LTD·Filed 2007·Granted May 31, 2011·37 cites·46 claims
- 0494US7868040B2Anti-cancer combinationsCANCER REC TECH LTD·Filed 2007·Granted Jan 11, 2011·26 cites·3 claims
- 0594US7585893B2Anti-cancer composition comprising DMXAA or related compoundCANCER REC TECH LTD·Filed 2005·Granted Sep 8, 2009·109 cites·9 claims
- 0693US8367658B2Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their useCANCER REC TECH LTD·Filed 2011·Granted Feb 5, 2013·16 cites·19 claims
- 0792US7510830B2Cancer treatment by combination therapyCANCER REC TECH LTD·Filed 2003·Granted Mar 31, 2009·115 cites·12 claims
- 0892US7462642B2Anti-cancer combinationsCANCER REC TECH LTD·Filed 2004·Granted Dec 9, 2008·110 cites·6 claims
- 0992US7351701B2Therapeutic compoundsCANCER REC TECH LTD·Filed 2004·Granted Apr 1, 2008·50 cites·6 claims
- 1090US7626011B2Antibodies against tumor surface antigensCANCER REC TECH LTD·Filed 2007·Granted Dec 1, 2009·18 cites·6 claims
- 1189US7235585B2Enzyme activated self-immolative n-substituted nitrogen mustard prodrugsCANCER REC TECH LTD·Filed 2003·Granted Jun 26, 2007·58 cites·53 claims
- 1289US7056690B2Detection of dysplastic or neoplastic cells using anti-MCM2 antibodiesCANCER REC TECH LTD·Filed 2001·Granted Jun 6, 2006·30 cites·9 claims
- 1388US9120789B21-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapyCANCER REC TECH LTD·Filed 2014·Granted Sep 1, 2015·7 cites·39 claims
- 1488US8383593B2αvβ6 peptide ligands and their usesCANCER REC TECH LTD·Filed 2006·Granted Feb 26, 2013·10 cites·8 claims
- 1588US7582440B2Imaging, diagnosis and treatment of diseaseCANCER REC TECH LTD·Filed 2006·Granted Sep 1, 2009·15 cites·15 claims
- 1688US7268126B2Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-ce]indol-6-oneCANCER REC TECH LTD·Filed 2005·Granted Sep 11, 2007·23 cites·6 claims
- 1788US7232888B2Antibodies against tumor surface antigensCANCER REC TECH LTD·Filed 2003·Granted Jun 19, 2007·25 cites·6 claims
- 1887US9394301B2[1,2,4]triazolo[1,5-a]pyridine and [1,2,4]triazolo[1,5-c]pyrimidine compounds and their useCANCER REC TECH LTD·Filed 2015·Granted Jul 19, 2016·9 cites·19 claims
- 1987US9358222B2Therapeutic agentsCANCER REC TECH LTD·Filed 2013·Granted Jun 7, 2016·9 cites·12 claims
- 2087US8912191B2Pyrido[2,3-B]pyrazin-8-substituted compounds and their useCANCER REC TECH LTD·Filed 2013·Granted Dec 16, 2014·8 cites·20 claims
- 2187US8383816B2Aryl-quinolyl compounds and their useCANCER REC TECH LTD·Filed 2009·Granted Feb 26, 2013·13 cites·29 claims
- 2287US7498034B2Imaging, diagnosis and treatment of diseaseCANCER REC TECH LTD·Filed 2001·Granted Mar 3, 2009·25 cites·33 claims
- 2386US7625922B2Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as therapeutic compoundsCANCER REC TECH LTD·Filed 2005·Granted Dec 1, 2009·19 cites·44 claims
- 2485US7459157B2Detection of dysplastic or neoplastic cells using anti-MCM2 antibodiesCANCER REC TECH LTD·Filed 2006·Granted Dec 2, 2008·7 cites·9 claims
- 2584US7531530B2Therapeutic compoundsCANCER REC TECH LTD·Filed 2004·Granted May 12, 2009·19 cites·15 claims
- 2684US6858633B1Substituted 2-arylbenzazole compounds and their use as antitumour agentsCANCER REC TECH LTD·Filed 2000·Granted Feb 22, 2005·28 cites·33 claims
- 2782US7740830B2Imaging, diagnosis and treatment of diseaseCANCER REC TECH LTD·Filed 2007·Granted Jun 22, 2010·5 cites·17 claims
- 2882US7674823B2DNA-PK inhibitorsCANCER REC TECH LTD·Filed 2007·Granted Mar 9, 2010·3 cites·7 claims
- 2981US7241618B2Expression systemCANCER REC TECH LTD·Filed 2002·Granted Jul 10, 2007·31 cites·16 claims
- 3081US7115619B2N8, N13 -disubstituted quino[4,3,2-kl]acridinium salts as therapeutic agentsCANCER REC TECH LTD·Filed 2001·Granted Oct 3, 2006·14 cites·58 claims
- 3180US9334286B2Pharmacologically active compoundsCANCER REC TECH LTD·Filed 2013·Granted May 10, 2016·4 cites·17 claims
- 3277US7160896B2Therapeutic acridone and acridine compoundsCANCER REC TECH LTD·Filed 2001·Granted Jan 9, 2007·11 cites·62 claims
- 3376US9012633B2[1,2,4]triazolo[1,5-a]pyridine and [1,2,4]triazolo[1,5-c]pyrimidine compounds and their useCANCER REC TECH LTD·Filed 2013·Granted Apr 21, 2015·3 cites·33 claims
- 3475US9040540B25-(pyridin-2-yl-amino)-pyrazine-2-carbonitrile compounds and their therapeutic useCANCER REC TECH LTD·Filed 2012·Granted May 26, 2015·7 cites·39 claims
- 3574US7816334B2Materials and methods relating to immune responses to fusion proteinsCANCER REC TECH LTD·Filed 2001·Granted Oct 19, 2010·4 cites·42 claims
- 3672US7205311B2Therapeutic acridone and acridine compoundsCANCER REC TECH LTD·Filed 2003·Granted Apr 17, 2007·8 cites·59 claims
- 3771US7868039B2Anti-cancer combinationsCANCER REC TECH LTD·Filed 2007·Granted Jan 11, 2011·0 cites·3 claims
- 3871US7235401B2Method for determining cell cycle positionCANCER REC TECH LTD·Filed 2002·Granted Jun 26, 2007·4 cites·6 claims
- 3971US7226918B2DNA-PK inhibitorsCANCER REC TECH LTD·Filed 2002·Granted Jun 5, 2007·4 cites·9 claims
- 4070US7105518B2Thiopyrane-4-ones as DNA protein kinase inhibitorsCANCER REC TECH LTD·Filed 2002·Granted Sep 12, 2006·5 cites·8 claims
- 4168US6656718B2Modified carboxypeptidase enzymes and their useCANCER REC TECH LTD·Filed 2001·Granted Dec 2, 2003·2 cites·10 claims
- 4268US2007060637A1Anti-cancer combinationsCANCER REC TECH LTD·Filed 2006·Application pending·0 cites
- 4367US7700822B2Modulation of cytochrome P450 reductase activityCANCER REC TECH LTD·Filed 2002·Granted Apr 20, 2010·4 cites·11 claims
- 4466US6787672B2Substituted chalcones as therapeutic compoundsCANCER REC TECH LTD·Filed 2001·Granted Sep 7, 2004·6 cites·89 claims
- 4565US7662625B2Methods for detecting the differentiation status of cells using 5T4 antigen expressionCANCER REC TECH LTD·Filed 2003·Granted Feb 16, 2010·6 cites·10 claims
- 4664US7863322B2Anti-cancer combinationsCANCER REC TECH LTD·Filed 2004·Granted Jan 4, 2011·0 cites·3 claims
- 4764US7312082B2Crystal structure of G-quadruplex containing a potassium ionCANCER REC TECH LTD·Filed 2003·Granted Dec 25, 2007·4 cites·2 claims
- 4863US7863320B2Anti-cancer combinationsCANCER REC TECH LTD·Filed 2007·Granted Jan 4, 2011·0 cites·3 claims
- 4963US7863321B2Anti-cancer combinationsCANCER REC TECH LTD·Filed 2007·Granted Jan 4, 2011·0 cites·6 claims
- 5063US7563818B2Photosensitizer functionalised nanoparticlesCANCER REC TECH LTD·Filed 2002·Granted Jul 21, 2009·3 cites·26 claims
Showing the top 50 of 87 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when CANCER REC TECH LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →